Testosterone Replacement Therapy-Low T Therapy (TRT)
Tens of thousands of lawsuits have been filed claiming men who have used testosterone replacement therapies (“TRT”) experienced serious cardiovascular events, including heart attacks, strokes, pulmonary embolisms, and deep vein thromboses. The plaintiffs filed suit against various manufacturers of TRTs, including AbbVie Inc., Eli Lilly & Co., Pfizer Inc., Endo International, who make products such as AndroGel and Depo-Testosterone.
The lawsuits claim testosterone products put healthy men in danger because the manufacturers marketed TRT for treatment of conditions that were never approved by the U.S. Food & Drug Administration (“FDA”), such as sexual dysfunction and age-related fatigue. Where the FDA’s approval was limited to a medical condition known as hypogonadism, drug makers’ campaign invented a condition call “Low T.” Research shows that TRT provides little or no benefit for the off-label uses.
According to a former sales manager, manufacturers allegedly recruited doctors to screen patients seeking Viagra for low testosterone even though it isn’t approved to treat erectile dysfunction. The end result was exposing mend to the serious side effects of TRT, this despite the FDA’s warnings regarding those risks.
The U.S. Judicial Panel on Multidistrict Litigation created a testosterone multidistrict litigation, or MDL, in June 2014 because of the complexity and number of parties to the lawsuit. AbbVie, Eli Lilly, Endo International, Auxilium Pharmaceuticals, GlaxoSmithKline and Allergan have tentatively reached confidential, global settlements for thousands of cases.
If you or a loved one has experiences serious cardiovascular events while on testosterone replacement therapy, contact the dangerous drug attorneys at Neumann Law Group for a free consultation. Our attorneys will review your case and evaluate your claims free of charge.